Evidence map›Paper›PMID 38030314›Full record

ArticleThe Lancet. Haematology2023

Life after sickle cell disease, is it really uhuru?

Lydia H Pecker, Adeseye M Akinsete, C Patrick Carroll, Sophie Lanzkron, Kevin H M Kuo, Monica Hulbert, Elizabeth Stenger, Deepika S Darbari

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Haematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lydia H PeckerDivision of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: lpecker1@jh.edu.
Adeseye M AkinseteDepartment of Pediatrics, College of Medicine, University of Lagos, Lagos, Nigeria.
C Patrick CarrollDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sophie LanzkronDivision of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Kevin H M KuoDivision of Hematology, Department of Medicine, University of Toronto, Toronto, Canada.
Monica HulbertDivision of Pediatric Hematology, Department of Pediatrics, Washington University, St Louis, MO, USA.
Elizabeth StengerAflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
Deepika S DarbariDivision of Hematology, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Funding

Development of a Clinical Hemoglobin ModulatorR33HL147845 · NHLBI · PHOENICIA BIOSCIENCES, INC. · PI FALLER, DOUGLAS V, KUO, KEVIN · 2020 to 2022
$5.2M
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell diseaseU01HL156620 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DEBAUN, MICHAEL R., FITZHUGH, COURTNEY D · 2021 to 2025
$4.1M
OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIAK23HL146841 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI PECKER, LYDIA · 2020 to 2024
$1.2M
NHLBI NIH HHS K23 HL146841NHLBI NIH HHS R33 HL147845NHLBI NIH HHS U01 HL156620
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Sickle CellHumansQuality of Life

Identifiers

PMID38030314
PMCPMC10957145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.